বাংলা | Epaper

বাংলা E-Paper 📍 Dhaka 📅 Wednesday | 21 October 2026, 5 Kartik 1433 PID registration number 06

HEADLINE

● Durga Puja celebrations end Wednesday ● ‘Our only identity is Bangladeshi’: PM ● Umrah pilgrims hit by Houthi attack return tonight ● PM vows to secure Bangladesh’s water share ● PM off to Ctg ● Maha Navami: Behind Durga’s battle against Mahishasura ● How to make front number plate for your bike

Saudi authority clarifies camel urine product registered as supplement

Published : Tuesday, 20 October, 2026 at 3:11 PM

Observer Online Report

Symbolic Photo

The Saudi Food and Drug Authority (SFDA) has refuted viral social media claims alleging that it approved a cancer treatment developed from components derived from camel urine, clarifying that the product in question is merely registered as a dietary supplement.

In a statement released on its official X account, the SFDA confirmed that the product highlighted in online discussions holds no approval as a medicinal treatment for cancer or any other disease.

According to the regulatory body, the product derived from camel urine components is registered strictly as a dietary supplement containing a blend of vitamins and minerals designed to meet daily nutritional requirements.

The SFDA emphasized that the approved scope of use for the product remains strictly limited to addressing nutritional deficits as a dietary supplement, carrying no recognized therapeutic claims or authorization for cancer treatment.

The authority urged the public to disregard false claims suggesting the item had been approved for medical oncology treatments.

-SA

Also read

Supertanker catches fire after hitting mine in Hormuz: IRGC

Iran rules out transfer of enriched nuclear material abroad

$900,000 Earhart search ends in disappointment

Scientists find two hidden magma sources

1 in 3 Pakistani adults faces mental health issues

Google Cloud outage hits Europe

Pakistan army chief visits Iran amid regional tensions

Kenyan preacher convicted over deaths of 191 children

Editor : Iqbal Sobhan Chowdhury

Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000.
Phone: PABX- 41053001-06; Advertisement: 41053012; 01793317829, 01550707291, E-mail: [email protected], ‍[email protected] Online: email: [email protected] 41053014; 01550707297 Advertisement: 01550707296

🔝